Leveraging Innovation To Deliver Precision Medicines

News & Events

Press Releases

20 October 2020

Jubilant Therapeutics Strengthens Scientific Advisory Board

22 June 2020

Jubilant Therapeutics Presents Preclinical Data at the American Association for Cancer Research, Reveals Unique Dual-Action Anti-Cancer Mechanism Underscoring First-in-Class Pipeline Asset in Hematological Tumors

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.